Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Stomach Neoplasms 1Pituitary Neoplasms 1Esophageal Neoplasms 1Colorectal Adenoma With Mild Dysplasia 1Barrett Esophagus 1

Interventions

pasireotide 3lanreotide 1Temozolomide 1Rosiglitazone 1Pafolacianine 1Endoscopic Mucosal Resection 1Dexamethasone 1Capecitabine 1Calcium Dobesilate 1Cabergoline 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pituitary Neoplasms × Endoscopic Mucosal Resection × Clear all
NCT03515603 2023-05-17

Endocrine Outcome of Surgery for Pituitary Adenoma

University of Ulm

Phase NA Terminated
36 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡